Bayer Kerendia Wins FDA Approval for Type 1 Diabetes CKD
Berlin, Germany, September 17, 2026 Bayer announced that the U.S. Food and Drug Administration (FDA) has approved Kerendia™ (finerenone)...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Berlin, Germany, September 17, 2026 Bayer announced that the U.S. Food and Drug Administration (FDA) has approved Kerendia™ (finerenone)...
Parsippany, New Jersey, USA & Tel Aviv, Israel, September 16, 2026 Teva Pharmaceuticals has launched LongActingImpact.com, a new educational...
Austin, Texas, USA, September 16, 2026 Sling Therapeutics, Inc. has announced that the first patients have been dosed in...
Pittsburgh, Pennsylvania, USA, September 15, 2026 The Braff Group has announced that its client, Community Clinical Research (CCR) of...
